OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16–25 years: a RCT.
Asherson P, Johansson L, Holland R, Bedding M, Forrester A, Giannulli L, Ginsberg Y, Howitt S, Kretzschmar I, Lawrie S, Marsh C, Kelly C, Mansfield M, McCafferty C, Khan K, Müller-Sedgwick U, Strang J, Williamson G, Wilson L, Young S, Landau S, Thomson L.
Asherson P, et al. Among authors: howitt s.
Southampton (UK): National Institute for Health and Care Research; 2022 Jun.
Southampton (UK): National Institute for Health and Care Research; 2022 Jun.
PMID: 35793424
Free Books & Documents.
Review.